- Rank
- 128th of 809
- Companies held
- 1
- Largest holding
- IBRX, 100.0% of total
- Latest SEC filing
- Mar 31, 2026
- Listed but not counted
- $3.32B
What the $1.40B is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| ImmunityBio IBRX Common Stock | Through NantBio, Inc. Reported jointly by 2 insiders; split evenly | 130,852,907 | $6.57 | $860M | 61.6% | Form 4, Mar 31, 2026 |
| ImmunityBio IBRX Common Stock | Directly | 29,757,911 | $6.57 | $196M | 14.0% | Form 4, Mar 31, 2026 |
| ImmunityBio IBRX Common Stock | Through NantCancerStemCell, LLC Reported jointly by 2 insiders; split evenly | 23,778,967 | $6.57 | $156M | 11.2% | Form 4, Mar 31, 2026 |
| ImmunityBio IBRX Common Stock | Indirectly (see filing footnote) Reported jointly by 2 insiders; split evenly | 16,303,493 | $6.57 | $107M | 7.7% | Form 4, Mar 31, 2026 |
| ImmunityBio IBRX Common Stock | Indirectly (see filing footnote) | 5,618,326 | $6.57 | $36.9M | 2.6% | Form 4, Mar 31, 2026 |
| ImmunityBio IBRX Common Stock | Through NantMobile, LLC Reported jointly by 3 insiders; split evenly | 3,328,973 | $6.57 | $21.9M | 1.6% | Form 4, Mar 31, 2026 |
| ImmunityBio IBRX Common Stock | Through California Capital Equity, LLC Reported jointly by 3 insiders; split evenly | 2,794,471 | $6.57 | $18.4M | 1.3% | Form 4, Mar 31, 2026 |
Share counts are the amounts California Capital Equity, LLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on California Capital Equity, LLC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| ImmunityBio IBRX Common Stock | Through Nant Capital, LLC Held by an investment fund or partnership | 251,018,873 | $6.57 | $1.65B | — | Form 4, Mar 31, 2026 |
| ImmunityBio IBRX Common Stock | Through Nant Capital, LLC Held by an investment fund or partnership | 246,412,277 | $6.57 | $1.62B | — | Form 4, Feb 22, 2026 |
| ImmunityBio IBRX Common Stock | Through Chan Soon-Shiong Family Foundation Held for a foundation or charity | 7,976,159 | $6.57 | $52.4M | — | Form 4, Mar 31, 2026 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 125 | Saba Capital Management, L.P. 10% owner, BlackRock ESG Capital Allocation Term Trust | $1.53B |
| 126 | Holding Frank B JR Chairman and CEO, First Citizens BancShares | $1.44B |
| 127 | Bryant Hope Holding Vice Chairwoman, First Citizens BancShares | $1.44B |
| 128 | California Capital Equity, LLC 10% owner, ImmunityBio | $1.40B |
| 129 | Ergen Two-Year June 2023 DISH GRAT 10% owner, EchoStar | $1.39B |
| 130 | Famatown Finance Ltd 10% owner, International Seaways | $1.39B |
| 131 | Electrum Strategic Opportunities Fund II L.P. Director, Sinda | $1.38B |
Other ImmunityBio insiders
All IBRX insiders- Barry J. Simon$18.3MDirector. #5565 overall
Questions
How much stock does California Capital Equity, LLC own?
California Capital Equity, LLC holds $1,395,698,266 in listed stock based on SEC filings and current prices, mostly ImmunityBio (IBRX). That ranks 128th on the Stock Rich List.
Is this California Capital Equity, LLC's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with SEC filer 1189020.